How is neulasta taken

You are now leaving Amgen's website www.amgencare.ie and entering another website. Amgen is not responsible for the content of this third-party website you are entering now and is not adopting such content into this website. If you want to leave www.amgencare.ie please click continue:

You are now leaving Amgen's website www.amgencare.ie and entering another website. Amgen is not responsible for the content of this third-party website you are entering now and is not adopting such content into this website. If you want to leave www.amgencare.ie please click continue:

You are now leaving Amgen's website www.amgencare.ie and entering another website. Amgen is not responsible for the content of this third-party website you are entering now and is not adopting such content into this website. If you want to leave www.amgencare.ie please click continue:

Return to Previous Page Continue

Always use this medicine exactly as your doctor has told you. Check with your doctor, nurse or pharmacist if you are not sure.

How is Neulasta® injected?

The usual dose is one 6 mg subcutaneous injection (injection under your skin) and it should be given at least 24 hours after your last dose of chemotherapy at the end of each chemotherapy cycle.

Where in the body is the injection given?

The Neulasta® injection can be given in the:1
  • Upper part of your thigh.
  • Belly, except for a 5 cm (2 inch) area right around your belly button.
  • Outer area of upper arm (only if someone else is giving you the injection).
neulasta-body

How to self-inject with Neulasta® pre-filled syringe with Automatic Needle Guard (ANG)

Your doctor may decide that it is best for you or a carer to inject Neulasta®. Your doctor, nurse or pharmacist will show you how to inject yourself with the pre-filled syringe. Do not try to inject yourself if you have not been trained.
The video below is broken up into 7 chapters for you to watch. These are intended to help you feel confident when using your syringe to inject Neulasta®. It will guide you, step by step, through the self-injection process – and demonstrate how, with practice, injecting can become a simple and routine part of your life.

Chapter 1:
Introduction

Play video

Chapter 2:
Important parts of the Pre-Filled Syringe with Automatic Needle Guard

Play video

Chapter 3:
Points to remember before using the Pre-Filled Syringe

Play video

Chapter 4:
Step 1 - Prepare your work area to perform the injection

Play video

Chapter 5:
Step 2 - Get ready to perform the injection

Play video

Chapter 6:
Step 3 - Perform the injection

Play video

Chapter 7:
Step 4 - Finish

Play video

You can find step by step instructions on how to use the Automatic Needle Guard (ANG) Pre-filled Syringe in the Patient Information Leaflet contained within the Neulasta® box.
Patient Information Leaflet (PIL) ➔

If you use more Neulasta® than you should

If you use more Neulasta® than you should contact your doctor, pharmacist or nurse.

If you forget to inject Neulasta®1

If you are injecting yourself and have forgotten your dose of Neulasta®, you should contact your doctor to discuss when you should inject the next dose.

References:

  1. Neulasta® (pegfilgrastim). Patient Information Leaflet. [Available at: https://www.medicines.ie/medicines/neulasta-pre-filled-syringe-34724/patient-info]

Reporting of side effects:

If you get any side effects, talk to your doctor, pharmacist or nurse. This includes any possible side effects not listed in the package leaflet. Side effects can be reported directly to the Health Products Regulatory Authority (HPRA) using the available methods via www.hpra.ie. By reporting side effects you can help provide more information on the safety of this medicine. Side effects should also be reported to Amgen Limited on +44 (0) 1223 436441 or Freephone 1800 535 160.
Please report any potential quality issue with the Amgen product you have received, by calling us on +44 (0) 1223 436441 or Freephone 1800 535 160 and providing us with the details. Please ensure that you keep your packaging, so we are able to identify your product more easily.
For a list of possible side effects, please see
Patient Information Leaflet (PIL)

© 2021 Amgen Inc. All rights reserved | IRL-3-0223-80005 May 23
Amgen Ireland Ltd - 21 Northwood Court, Santry, Dublin 9, Ireland